These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents. Cole HD; Vali A; Roque JA; Shi G; Kaur G; Hodges RO; Francés-Monerris A; Alberto ME; Cameron CG; McFarland SA Inorg Chem; 2023 Dec; 62(51):21181-21200. PubMed ID: 38079387 [TBL] [Abstract][Full Text] [Related]
5. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups. McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351 [TBL] [Abstract][Full Text] [Related]
6. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents. Wang L; Yin H; Cui P; Hetu M; Wang C; Monro S; Schaller RD; Cameron CG; Liu B; Kilina S; McFarland SA; Sun W Dalton Trans; 2017 Jun; 46(25):8091-8103. PubMed ID: 28604869 [TBL] [Abstract][Full Text] [Related]
7. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity. Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972 [TBL] [Abstract][Full Text] [Related]
8. Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy. Roque JA; Barrett PC; Cole HD; Lifshits LM; Shi G; Monro S; von Dohlen D; Kim S; Russo N; Deep G; Cameron CG; Alberto ME; McFarland SA Chem Sci; 2020 Sep; 11(36):9784-9806. PubMed ID: 33738085 [TBL] [Abstract][Full Text] [Related]
9. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands. Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079 [TBL] [Abstract][Full Text] [Related]
10. Future potential of osmium complexes as anticancer drug candidates, photosensitizers and organelle-targeted probes. Zhang P; Huang H Dalton Trans; 2018 Oct; 47(42):14841-14854. PubMed ID: 30325378 [TBL] [Abstract][Full Text] [Related]
11. Ru(II) Oligothienyl Complexes with Fluorinated Ligands: Photophysical, Electrochemical, and Photobiological Properties. Cole HD; Vali A; Roque JA; Shi G; Talgatov A; Kaur G; Francés-Monerris A; Alberto ME; Cameron CG; McFarland SA Inorg Chem; 2024 May; 63(21):9735-9752. PubMed ID: 38728376 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers. Liu ZY; Zhang J; Sun YM; Zhu CF; Lu YN; Wu JZ; Li J; Liu HY; Ye Y J Mater Chem B; 2020 Jan; 8(3):438-446. PubMed ID: 31833531 [TBL] [Abstract][Full Text] [Related]
13. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia. Liu X; Li G; Xie M; Guo S; Zhao W; Li F; Liu S; Zhao Q Dalton Trans; 2020 Aug; 49(32):11192-11200. PubMed ID: 32748922 [TBL] [Abstract][Full Text] [Related]
14. Photoactivated Osmium Arene Anticancer Complexes. Xue X; Fu Y; He L; Salassa L; He LF; Hao YY; Koh MJ; Soulié C; Needham RJ; Habtemariam A; Garino C; Lomachenko KA; Su Z; Qian Y; Paterson MJ; Mao ZW; Liu HK; Sadler PJ Inorg Chem; 2021 Dec; 60(23):17450-17461. PubMed ID: 34503331 [TBL] [Abstract][Full Text] [Related]
15. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands. Sanz-Villafruela J; Bermejo-Casadesús C; Martínez-Alonso M; Moro A; Lima JC; Massaguer A; Espino G Dalton Trans; 2024 Jul; 53(27):11393-11409. PubMed ID: 38899369 [TBL] [Abstract][Full Text] [Related]
16. Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia. Roque Iii JA; Cole HD; Barrett PC; Lifshits LM; Hodges RO; Kim S; Deep G; Francés-Monerris A; Alberto ME; Cameron CG; McFarland SA J Am Chem Soc; 2022 May; 144(18):8317-8336. PubMed ID: 35482975 [TBL] [Abstract][Full Text] [Related]
17. Structurally Simple Osmium(II) Polypyridyl Complexes as Photosensitizers for Photodynamic Therapy in the Near Infrared. Mani A; Feng T; Gandioso A; Vinck R; Notaro A; Gourdon L; Burckel P; Saubaméa B; Blacque O; Cariou K; Belgaied JE; Chao H; Gasser G Angew Chem Int Ed Engl; 2023 May; 62(20):e202218347. PubMed ID: 36917074 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers. Mo J; Mai Le NP; Priefer R Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979 [TBL] [Abstract][Full Text] [Related]
19. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers. Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123 [TBL] [Abstract][Full Text] [Related]
20. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy. Heinemann F; Karges J; Gasser G Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]